CLINICAL CORNER

Drug Recall – Levsin (Hyoscyamine sulfate) 0.125mg

Seven batches of Hyoscyamine 0.125 mg tablets, sublingual, and oral disintegrating tables have been recalled.  This recall is being initiated due to both superpotent and subpotent test results.

Contract Pharmacy Services has purchased this product.  A pharmacy representative will directly contact those facilities that have current active orders to ensure the product is removed and returned to the pharmacy.

If you receive medications from a source other than CPS please ensure you check your current supply and contact your pharmacy for direction.

Taking a product that is superpotent could result in hot/dry skin, fever, blurred vision, sensitivity to light, dry mouth, unusual excitement, fast or irregular heartbeat, dizziness, an inability to completely empty the bladder, and seizures. The severity of the adverse event would depend on how superpotent the tablet was. Adverse events such as clotted blood within the tissues and fractures could occur, as a result of falls from dizziness or seizures if the strength is particularly high. To date the manufacturer has received three adverse event reports involving hallucinations, stroke-like symptoms, confusion, dizziness, blurred vision, dry mouth, slurred speech, imbalance, and disorientation.

Please the pharmacy at 800.333.5012 with any questions.

Footer Logo

CONTACT US